Bambusa Therapeutics, Inc. (BBTX) revenue by segment
BBTXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$15.90−0.45 (-2.75%)
Close on Nov 18, 2026Market cap –P/E –Yield –
See a number that looks wrong?
Close on Nov 18, 2026Market cap –P/E –Yield –
See a number that looks wrong?